Advertisement
Advertisement
August 14, 2018
AngioDynamics Acquires Surgical Specialties' BioSentry System
August 15, 2018—AngioDynamics, Inc. announced the acquisition of the BioSentry tract sealant system technology from Surgical Specialties, LLC, a medical device company headquartered in Westwood, Massachusetts. Additionally, Surgical Specialties’ 12-person commercial organization will join AngioDynamics' Oncology business.
According to the company, the commercialized BioSentry product minimizes the occurrence of pneumothorax (PTX), which is a complication of CT-guided percutaneous lung biopsy. The technology's hydrogel plug prevents air leakage during the biopsy procedure to mitigate the risk of PTX.
The BioSentry system was approved by the FDA in December 2012 and commercially launched in 2013. It has also received European CE Mark approval.
Advertisement
Advertisement
